Among active 13F managers last quarter, 8 opened and 23 added, while 15 reduced; the largest holder to move was Janus Henderson Group Ltd. (+1.3%). Over the last 180 days, 2 insiders sold and none bought, a net -$1.0M in open-market trades.
The legs disagree, or only one of them leans.
107 tracked 13F filers disclose a position in TARA as of the latest SEC 13F filings, a combined $182.3M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Ltd. | 5.2M | $27.2M | ▲+1.3% Added · +65K sh | Q1 2026 | |
| 2 | BlackRock, Inc. | 3.7M | $14.0M | ▲+7.9% Added · +269K sh | Q2 2026 | |
| 3 | Velan Capital Investment Management LP | 2.8M | $10.9M | ▲+0.3% Added · +10K sh | Q2 2026 | |
| 4 | Millennium Management LLC | 2.8M | $14.8M | ▲+276% Added · +2.1M sh | Q1 2026 | |
| 5 | Vanguard Capital Management LLC | 2.3M | $8.8M | ▲+8.5% Added · +181K sh | Q2 2026 | |
| 6 | Blackstone Inc. | 2.3M | $11.8M | ▲+19% Added · +356K sh | Q1 2026 | |
| 7 | Orbimed Advisors LLC | 2.2M | $8.5M | ▲New +2.2M sh | Q2 2026 | |
| 8 | Acorn Capital Advisors, LLC | 1.8M | $6.7M | —Held | Q2 2026 | |
| 9 | Integral Health Asset Management, LLC | 1.5M | $5.7M | ▼−14% Reduced · −250K sh | Q2 2026 | |
| 10 | UBS Group AG | 1.4M | $7.3M | ▲+15% Added · +187K sh | Q1 2026 | |
| 11 | 5AM Venture Management, LLC | 1.4M | $5.2M | —Held | Q2 2026 | |
| 12 | Geode Capital Management, LLC | 1.3M | $5.1M | ▲+13% Added · +149K sh | Q2 2026 | |
| 13 | Citadel Advisors LLC | 1.2M | $4.7M | ▲+15% Added · +164K sh | Q2 2026 | |
| 14 | State Street Corp | 1.1M | $4.1M | ▲+6.3% Added · +63K sh | Q2 2026 | |
| 15 | Baker Bros. Advisors LP | 972K | $3.7M | —Held | Q2 2026 | |
| 16 | ADAR1 Capital Management, LLC | 941K | $4.9M | ▼−17% Reduced · −196K sh | Q1 2026 | |
| 17 | Bank Of America Corp | 926K | $4.8M | ▲+87% Added · +430K sh | Q1 2026 | |
| 18 | Morgan Stanley | 557K | $2.9M | ▲+218% Added · +382K sh | Q1 2026 | |
| 19 | Point72 Asset Management, L.P. | 549K | $2.1M | ▼−52% Reduced · −604K sh | Q2 2026 | |
| 20 | Dimensional Fund Advisors LP | 531K | $2.8M | ▲+134% Added · +304K sh | Q1 2026 | |
| 21 | Catalio Capital Management, LP | 520K | $2.0M | ▼−10% Reduced · −60K sh | Q2 2026 | |
| 22 | Walleye Capital LLC | 505K | $1.9M | ▲+14% Added · +62K sh | Q2 2026 | |
| 23 | Vanguard Portfolio Management LLC | 492K | $1.9M | ▲+19% Added · +79K sh | Q2 2026 | |
| 24 | Goldman Sachs Group Inc | 398K | $2.1M | ▲+527% Added · +334K sh | Q1 2026 | |
| 25 | Northern Trust Corp | 375K | $2.0M | ▲+56% Added · +134K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 8 funds opened a new position in TARA and 23 added to an existing one, while 15 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Nvidia CorpNVDA | 46 funds | $185.7B |
| Eli Lilly & CoLLY | 46 funds | $39.8B |
| Microsoft CorpMSFT | 45 funds | $104.4B |
| Amazon.com IncAMZN | 45 funds | $81.5B |
| Alphabet Inc-CL AGOOGL | 45 funds | $74.6B |
| Broadcom IncAVGO | 45 funds | $74.0B |
| Visa Inc-Class A SharesV | 45 funds | $23.6B |
| Bank Of America CorpBAC | 45 funds | $12.3B |
| Centene CorpCNC | 45 funds | $2.9B |
| Meta Platforms Inc-Class AMETA | 44 funds | $46.1B |
| Advanced Micro DevicesAMD | 44 funds | $31.4B |
| JPMorgan Chase & CoJPM | 44 funds | $27.6B |
Ranked by how many of TARA's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in TARA.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | Shefferman Jesse | CEO and President, Director | Sell (S) | 216K | $882K |
| Apr 8, 2026 | Zummo Jacqueline | Chief R&D Officer | Sell (S) | 1K | $6K |
| Apr 1, 2026 | Zummo Jacqueline | Chief R&D Officer | Sell (S) | 23K | $119K |
| May 14, 2025 | Levy Richard S | Director | Buy (P) | 20K | $64K |
| Mar 26, 2025 | Zummo Jacqueline | Chf Scientific Operations Off | Sell (S) | 21K | $96K |
| Sep 12, 2024 | Opaleye Management Inc. | 10% Owner | Sell (S) 2 lots, same day | 126K | $216K |
| Sep 11, 2024 | Opaleye Management Inc. | 10% Owner | Sell (S) 2 lots, same day | 33K | $56K |
| Sep 10, 2024 | Opaleye Management Inc. | 10% Owner | Sell (S) 2 lots, same day | 26K | $45K |
| Sep 9, 2024 | Opaleye Management Inc. | 10% Owner | Sell (S) 2 lots, same day | 36K | $69K |
| Jul 16, 2024 | Opaleye Management Inc. | 10% Owner | Sell (S) 2 lots, same day | 11K | $28K |
| Jul 11, 2024 | Opaleye Management Inc. | 10% Owner | Sell (S) 2 lots, same day | 48K | $115K |
| Jul 10, 2024 | Opaleye Management Inc. | 10% Owner | Sell (S) 2 lots, same day | 18K | $42K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 51 | 23 | – |
Insiders Form 4 open-market | 0 | 2 | -$1.0M |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for TARA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/TARA/capital-change-brief"
Use Arkolith's capital_change_brief for TARA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for TARA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.